Use of Nitrous Oxide for Pediatric Dental Patients

Board takeaway

Nitrous oxide/oxygen can reduce anxiety and discomfort when the child accepts the hood and breathes through the nose. It complements reassurance and local anesthesia; it does not provide reliable pulpal anesthesia or postoperative analgesia.

• Titrate: Use the minimum effective concentration, usually 30–40%, and do not routinely exceed 50%.
• Monitor: The child's responsiveness and breathing determine monitoring and rescue needs.
• Recover: Finish with 100% oxygen for at least five minutes and until baseline status returns; gas concentration alone does not establish safe discharge.

Decision map

Loading diagram…

Review the full contraindication/consultation list below, including closed gas spaces, untreated vitamin B12 deficiency, recent relevant surgery, and medication interactions. Nasal breathing and hood acceptance are prerequisites. A concentration ≤50% does not guarantee minimal sedation; monitoring follows actual response. Give 100% oxygen for at least five minutes after stopping nitrous oxide and continue until baseline responsiveness returns.

Effects, goals, and evidence

• Goals: reduce fear, movement, gagging, and fatigue; raise pain reaction threshold; improve communication and future dental attitudes; provide an amnesic effect.
• Analgesia involves endogenous opioid and descending inhibitory pathways; anxiolysis involves GABA-A activity. NMDA antagonism contributes to analgesic, anesthetic, and amnestic effects.
• Weak inhalation agent; rapid onset/recovery (2–3 minutes), pulmonary elimination without biotransformation, little renal/hepatic effect. Blood pressure generally is maintained despite minor cardiac-output depression.
• Reduces pressure-related pain but does not change pulpal sensitivity; no postoperative analgesia. Hood may obstruct anterior maxillary access.
• Literature-based best practice; insufficient or inconclusive data were supplemented by expert/consensus opinion. Findings from prolonged, higher-concentration general anesthesia may not translate directly to dental exposure.

Select the patient

• Review medical/dental history, emotional and physical development, treatment needs, quality-of-care benefit, and alternative behavior guidance.
• ASA I–II: appropriate candidates. ASA III, special health care needs, airway abnormalities, and moderate/severe tonsillar hypertrophy require individual assessment.
• Indications: anxiety; selected muscular tone disorders causing involuntary movement; interfering gag reflex; inability to obtain profound local anesthesia/analgesia; cooperative child fatigued by lengthy treatment.
• Mouth breathing, uncontrolled crying, hood refusal, congestion, sinus infection, URI, or active tuberculosis can reduce effectiveness. Claustrophobia or perceived loss of control may limit acceptance.
• Asthma alone is not a contraindication: the gas is nonirritating, and reduced stress may help.

Contraindications and consultation

• Listed potential contraindications include:
  • Respiratory/nasal: chronic obstructive pulmonary disease (COPD); upper respiratory infection (URI), sinusitis, or allergies impairing nasal breathing.
  • Ear and surgery history: recent middle-ear disturbance/infection; ear, nose, and throat (ENT) surgery within 14 days.
  • Eye conditions: raised intraocular pressure/glaucoma or up to 3 months after retinal surgery.
  • Other conditions/exposures: severe emotional disturbance or drug dependency; first-trimester pregnancy; bleomycin treatment; untreated vitamin B12 deficiency.
• Gas-space expansion also excludes patients with bowel obstruction or recent relevant surgery, such as craniotomy or correction of intestinal obstruction.
• Consult relevant specialists whenever possible for significant disease: severe pulmonary disease, emphysema, cystic fibrosis, heart failure, sickle cell disease, acute otitis media, recent tympanic graft, or severe head injury.
• Avoid use after severe head/neck trauma until cleared of intracranial injury or concussion. Consult the prenatal provider before use during pregnancy.
• N₂O irreversibly inactivates B12, potentially impairing myelin/DNA synthesis. Vegan/vegetarian diets can increase deficiency risk; diet alone is not listed as a contraindication.
• Medication-label guidance: avoid nitrous oxide anesthesia in patients receiving methotrexate; the combination can increase severe methotrexate adverse reactions through folate-dependent metabolic pathways. This supplements the AAPD guidance above. Methotrexate prescribing information.
• MTHFR: evidence conflicts and risk appears exposure-dependent; brief exposure may be less consequential. Severe deficiency may warrant geneticist/anesthesiologist consultation. Prophylactic B12 findings are equivocal; dental-specific metabolic evidence remains incomplete.

Titrate to response and confirm recovery

• Fit the nasal hood. Typical flow: 5–7 L/min for older children/adults; 3–5 L/min for ages 3–4. Adjust so the reservoir bag gently moves with breathing without over/underinflation.
• Standard titration: 100% oxygen for 1–2 minutes, then increase N₂O in 10% increments. The source also describes fixed-concentration rapid induction without titration.
• Adjust concentration to stimulation and response; retain reassurance and conventional behavior guidance. One study found no benefit to continuing N₂O after profound anesthesia was established.
• Above 60%, ataxia, giddiness, dysphoria, sleepiness, or delirium may impair cooperation. Higher concentrations have not consistently improved restorative-treatment behavior.
• Flowmeter concentration differs from alveolar concentration. Minimize talking/mouth breathing; avoid scavenging suction strong enough to interfere with adequate gas ventilation.
• Stop N₂O; give 100% oxygen for at least 5 minutes and until baseline status returns. Longer oxygenation may help after nausea/vomiting with prolonged exposure.

Monitor the actual response

• Continuously observe responsiveness to commands, color, respiratory rate, and rhythm. Relaxed limbs/jaw, eyelid drooping, open palms, and reduced heart rate may indicate effect.
• Additional sedating medication beyond local anesthesia, or maintained N₂O above 50%, increases deeper-sedation likelihood. Even ≤50% can produce moderate sedation in some patients; monitoring follows actual response.
• Nausea/vomiting: 0.5–1.2%; risk rises with duration, higher/fluctuating concentration, absent titration, and heavy meals. Fasting is not required for N₂O/O₂ analgesia/anxiolysis; a light meal sometimes is suggested.
• Other effects: oversedation, sweating, dysphoria, agitation/panic, dizziness, headache, hallucination, diffusion hypoxia, and gas-space expansion.
• Diffusion hypoxia follows rapid gas washout into alveoli, diluting oxygen. Postprocedure oxygen reduces this risk.
• Adverse outcomes have been reported with >50%, >45 minutes, and major-surgery anesthesia; these are associations, not a stated absolute time limit. At 70%, laryngospasm and rare silent regurgitation/aspiration are concerns.

Document care and prepare equipment for rescue

• Record parental informed consent before administration; dietary instructions if indicated; indication, gas percentage and/or flow, procedure duration, and posttreatment oxygenation.
• Verify new installations and calibrate/check delivery and fail-safe function under applicable state rules. Equipment must deliver 100% oxygen and never < 30%, with child-appropriate flow.
• Fail-safe stops N₂O when oxygen delivery falls below the established minimum (example 2.5–3 L/min). Include emergency air inlet, positive-pressure connection, oxygen flush, and effective scavenging.
• Inspect components; replace cracked/worn/torn parts immediately. Check pressure connections for leaks at startup and tank changes; follow compressed-gas storage rules. Access locks may deter misuse.
• Practitioner must have training, personnel, facilities, and rescue capability for foreseeable complications and deeper sedation. All clinical personnel require BLS training/certification and periodic emergency drills.
• Accessible pediatric emergency cart; positive-pressure oxygen >90% at 10 L/min for ≥60 minutes (650-L E cylinder). Self-inflating bag-mask oxygen flow: 15 L/min recommended. Document scheduled equipment/drug checks; mandated state requirements supersede recommendations.
• Fire prevention: recognize oxidizer + ignition + fuel; monitor gas flow, use high-volume suction ≥1 minute before an ignition source, maintain a moist field, and avoid dry cutting.

Occupational and environmental safety

• Use scavenging, ventilation, well-fitting hoods, leak checks, and periodic system maintenance; rubber dam, high-speed suction, larger operatories, and shorter exposure can reduce ambient gas.
• Limit patient talking/mouth breathing. Dentist exposure often exceeds assistant exposure.
• Historical unscavenged-exposure studies suggested reproductive, neurologic, hepatic, and renal harm. Modern evidence is scarce/inconsistent; exposure thresholds for harm remain undefined. Scavenged-office studies did not show significantly elevated infertility/miscarriage risks.
• N₂O contributes to greenhouse effects; the source estimates medical use accounts for < 1% of global N₂O pollution.

Common board traps

Answer aloud

Is nitrous oxide appropriate for an anxious child with nasal congestion?

Reassess nasal airflow and illness before proceeding; impaired nasal breathing reduces effectiveness and is a potential contraindication.

• The child must accept the hood and breathe through the nose.
• Reconsider timing or behavior guidance if congestion, uncontrolled crying, or hood refusal prevents delivery.
• Do not increase concentration to overcome an unsuitable delivery route.

How do you titrate nitrous oxide/oxygen and complete recovery?

Titrate to the minimum effective concentration, then give oxygen until baseline recovery.

• Start 100% oxygen for 1–2 minutes; increase nitrous oxide in 10% increments.
• Usually 30–40% is effective; do not routinely exceed 50%.
• Stop nitrous oxide; give 100% oxygen for at least five minutes and until pretreatment status returns.
• Document concentrations/flow, duration, response, and posttreatment oxygenation.

A child becomes less responsive at 50% nitrous oxide. What governs care?

Actual sedation depth governs monitoring and rescue, not the flowmeter percentage.

• Reassess breathing and responsiveness immediately and manage the deeper response.
• Moderate sedation can occur even at 50% or less.
• Added sedating medication or concentrations above 50% increase deeper-sedation likelihood.

What medical findings may make nitrous oxide unsuitable or require consultation?

Review gas-space, respiratory, and vitamin B12 risks before selecting nitrous oxide.

• Untreated B12 deficiency and bowel obstruction exclude this approach; diet alone does not diagnose deficiency.
• Recent ENT surgery within 14 days, middle-ear disease, glaucoma/retinal surgery history, bleomycin, and first-trimester pregnancy are listed potential contraindications.
• Significant disease or severe MTHFR deficiency may need specialist consultation.
• Methotrexate avoidance comes from its medication label, not this AAPD best practice.

Is fasting required for nitrous oxide analgesia/anxiolysis alone?

No, although a light meal may be suggested and heavy meals increase nausea/vomiting concerns.

• Nausea/vomiting occurs in approximately 0.5–1.2%; duration, concentration, and absent titration affect risk.
• Do not extend the no-fasting statement to combined-agent sedation.
• Nitrous oxide does not provide reliable pulpal anesthesia or postoperative analgesia.